AllergyIntolerance
Readiness: In development.
Open AllergyIntolerance profile on Simplifier
Profile base: FHIR R4 AllergyIntolerance. This is a narrow local recording profile, not a complete allergy-exchange profile.
Design choices
The profile fills a specific gap: reported allergy or intolerance information for which no corresponding structured record is already available in the source EHR, DigiDOT or Kjernejournal. Keeping Kjernejournal information as a separate source preserves its provenance and lifecycle instead of creating a competing local copy.
The causative-agent selection uses the SNOMED CT substance and product hierarchy branches also used by the International Patient Summary. That reuse does not make the profile IPS- or EU Core-conformant. Search, selection and any source mapping belong to the EHR; central storage does not generate additional allergy codings.
The draft deliberately records the assertion without structured reaction-event detail. Narrative can preserve relevant history and uncertainty, but this is a narrower representation than the full FHIR resource.
Use in practice
A patient reports a latex allergy that has not been recorded structurally elsewhere. The clinician can retain that report without presenting it as a verified diagnosis. The person reporting it, the clinician recording it and the technical sender need not be the same person.
An existing Kjernejournal alert should remain associated with that source. A consuming system may present information from several sources together while preserving the distinctions. Absence of a local DigiDOT allergy record does not establish that the patient has no allergies.
EHDS and later FHIR versions
The EHDS Allergy intolerance model includes reaction events, manifestations and other information beyond the current local scope. A future patient-summary exchange needs a gap assessment and source-selection rules; it cannot assume this narrow record contains the complete allergy history.
FHIR R5 AllergyIntolerance replaces recorder/asserter with participants and changes reaction manifestations to CodeableReference. Attribution must be mapped explicitly during migration, and any expansion of reaction content is a separate scope decision. See the shared assessment.
Compare the local allergy and medication responsibilities in Medication and allergy.